FDA Orange Book · active-ingredient family
Chloramphenicol; hydrocortisone acetate
Chloramphenicol; hydrocortisone acetate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:CHLOROMYCETIN HYDROCORTISONE · NDA 050202
1
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · for suspension
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| CHLOROMYCETIN HYDROCORTISONE | PARKEDALE | NDA 050202 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Chloramphenicol; hydrocortisone acetate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
